These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 4138027

  • 1. Tumor growth in the guinea pig: alpha globulin changes associated with lymphocyte suppression.
    Lilley DP, Burger DR, Vetto RM.
    J Natl Cancer Inst; 1974 Sep; 53(3):701-9. PubMed ID: 4138027
    [No Abstract] [Full Text] [Related]

  • 2. In vitro activity of lymphocytes and serum of C3Hf-Bu mice during the growth of methylcholanthrene-induced tumor and its regression following local irradiation.
    Jurin M, Suit HD.
    Cancer Res; 1974 Apr; 34(4):672-8. PubMed ID: 4814987
    [No Abstract] [Full Text] [Related]

  • 3. Further studies on the antigen composition of a mouse sarcoma.
    Krüger G.
    Z Krebsforsch; 1969 Apr; 73(2):164-71. PubMed ID: 4191607
    [No Abstract] [Full Text] [Related]

  • 4. Effect of different cancer treatment methods on immunity to an antigenic transplantable murine fibrosarcoma (Meth A).
    Khafagy M, Wanebo HJ, Alfieri A, Hahn EW.
    AJR Am J Roentgenol; 1977 Jun; 128(6):1027-9. PubMed ID: 414534
    [No Abstract] [Full Text] [Related]

  • 5. Proceedings: Evaluation of immune status in tumor patients.
    Vetto RM, Burger DR, Lilley DP.
    Arch Surg; 1974 Apr; 108(4):558-60. PubMed ID: 4131415
    [No Abstract] [Full Text] [Related]

  • 6. Lymphocyte suppression associated with alpha globulin. Changes in cellular immunity.
    Burger DR, Lilley DP, Vetto RM.
    Cell Immunol; 1974 Mar 15; 10(3):432-41. PubMed ID: 4141932
    [No Abstract] [Full Text] [Related]

  • 7. Discussion paper: in vitro augmentation of tumor immunity in a murine methylcholanthrene sarcoma system.
    Yarlott MA, McKhann CF.
    Ann N Y Acad Sci; 1976 Mar 15; 277(00):533-40. PubMed ID: 187102
    [No Abstract] [Full Text] [Related]

  • 8. In vivo and in vitro studies of the influence of the immune status of C3Hf-Bu mice on the effectiveness of local irradiation of a methylcholanthrene-induced fibrosarcoma.
    Jurin M, Suit HD.
    Cancer Res; 1972 Oct 15; 32(10):2201-11. PubMed ID: 5080765
    [No Abstract] [Full Text] [Related]

  • 9. The role of the spleen in the immunity to a chemically induced sarcoma in C3H mice.
    Bard DS, Pilch YH.
    Cancer Res; 1969 May 15; 29(5):1125-31. PubMed ID: 5781103
    [No Abstract] [Full Text] [Related]

  • 10. Splenic cellular responses in vitro after tumour-immunization.
    Liao SK, Carr DH.
    Experientia; 1973 May 15; 29(5):604-5. PubMed ID: 4354199
    [No Abstract] [Full Text] [Related]

  • 11. Immunological resistance to pulmonary metastases in C3Hf-Bu mice bearing syngeneic fibrosarcoma of different sizes.
    Milas L, Hunter N, Mason K, Withers HR.
    Cancer Res; 1974 Jan 15; 34(1):61-71. PubMed ID: 4809463
    [No Abstract] [Full Text] [Related]

  • 12. The effect of immunoregulatory globulin (IRA) upon lymphocytes in vitro.
    Cooperband SR, Badger AM, Davis RC, Schmid K, Mannick JA.
    J Immunol; 1972 Jul 15; 109(1):154-63. PubMed ID: 4113793
    [No Abstract] [Full Text] [Related]

  • 13. Tumor-secific immunity to chemically induced tumors. Evidence for immunologic specificity and shared antigenicity in lymphocyte responses to soluble tumor antigens.
    Frbes JT, Nakaw Y, Smith RT.
    J Exp Med; 1975 May 01; 141(5):1181-200. PubMed ID: 47896
    [Abstract] [Full Text] [Related]

  • 14. Host immunity to a growing transplanted methylcholanthrene-induced guinea pig sarcoma.
    Cohen AM, Millar RC, Ketcham AS.
    Cancer Res; 1972 Nov 01; 32(11):2421-6. PubMed ID: 5082590
    [No Abstract] [Full Text] [Related]

  • 15. Enhancement of tumour homografts by the local graft-versus-host reaction.
    Medzihradský J, Klobusická M, Koníková E, Novotná L.
    Neoplasma; 1971 Nov 01; 18(2):133-40. PubMed ID: 4397019
    [No Abstract] [Full Text] [Related]

  • 16. Changes in spleen morphology and lymphoid cell activity during tumor progression.
    Yamagishi H, Pellis NR, Macek C, Kahan BD.
    Eur J Cancer (1965); 1980 Nov 01; 16(11):1417-26. PubMed ID: 7227418
    [No Abstract] [Full Text] [Related]

  • 17. Passive transfer of tumor-specific resistance to methylcholanthrene-induced sarcomas in rats.
    Ishikawa Y, Fukushima M, Sato T, Komaba M, Yagihashi H.
    Tohoku J Exp Med; 1971 Feb 01; 103(2):195-201. PubMed ID: 5580594
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Tumor-specific immunogenicity of transplantable chemically induced tumors, as demonstrated by uptake of tritiated thymidine by lymphoid cells from isogenic and F1 hybrid mice.
    Phillips ME.
    J Natl Cancer Inst; 1974 Dec 01; 53(6):1665-70. PubMed ID: 4436867
    [No Abstract] [Full Text] [Related]

  • 20. Regression of established methylcholanthrene tumors by intratumor injections of Vbrio cholerae neuraminidase.
    Simmons RL, Rios A, Ray PK.
    J Surg Oncol; 1972 Dec 01; 4(4):298-305. PubMed ID: 5083567
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.